Radiolabeled annexin-V for monitoring treatment response in oncology

Cancer Biotherapy and Radiopharmaceuticals

Volumn 19, Issue 2, 2004, Pages 189-194

  Van De Wiele, Christophe ^a   Vermeersch, Hubert ^a   Loose, David ^a   Signore, Alberto ^b   Mertens, Nico ^c   Dierckx, Rudi ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Roma La Sapienza 2   (Italy)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Annexin V treatment response monitoring; Oncology

Indexed keywords

LIPOCORTIN 5; LIPOCORTIN 5 APOMATE TC 99M; LIPOCORTIN 5 ETHYLENEDICYSTEINE TC 99M; LIPOCORTIN 5 HYDRAZINONICOTINAMIDE TC 99M; LIPOCORTIN 5 I 123; LIPOCORTIN 5 N1 IMINO 4 MERCAPTOBUTYL TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER PATIENT; CELL DEATH; CONFERENCE PAPER; DRUG UPTAKE; HUMAN; ISOTOPE LABELING; NONHUMAN; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ANIMALS; ANNEXIN A5; CLINICAL TRIALS; DRUG EVALUATION, PRECLINICAL; HUMANS; ISOTOPE LABELING; NEOPLASMS;

EID: 2542466628     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497804323071968     Document Type: Conference Paper

References (39)

1. White E. Life, death, and the pursuit of apoptosis. Gene Dev 1996;10:1.
2. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305.
3. Evan G, Littlewood T. A matter of life and cell death. Science 1998;281:1317.
4. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309.
5. Thornberry NA, Laebnik Y. Caspases: Enemies within. Science 1998;281:1312.
6. Dive C, Hickman JA. Drug-target interactions: Only the first step in the commitment to a programmed cell death? Br J Cancer 1991;64:192.
7. Schmitt CA, Lowe S. Apoptosis and therapy. J Pathol 1999;187:127.
8. Zhivotovsky B, Joseph B, Orrenius S. Tumor radiosensitivity and apoptosis. Exp Cell Res 1999;248:10.
9. Mesner P, Rudthardjo I, Kaufman SH. Chemotherapy-induced apoptosis. Adv Pharmacol 1997;41:461.
10. Kaufman SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000;256:42.
11. Meyn RE, Stephens LC, Ang KK, et al. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Radiat Biol 1993;64:583.
12. Stephens LC, Ang KK, Schultheiss TE, et al. Apoptosis in irradiated murine tumor. Radiat Res 1991;127:308.
13. Meyn RL, Milas L, Stephens LC. Apoptosis in tumor biology and therapy. Adv Exp Med Biol 1997;400:657.
14. Milas L, Hunter RN, Kurdoglo B, et al. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemoth Pharm 1995;35:297.
15. Meyn RE, Stephens LC, Hunter NR, et al. Induction of apoptosis in murine tumors by cyclophosphamide. Cancer Chemoth Pharm 1994;33:410.
16. Ellis PA, Smith IE, McCarthy K, et al. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet 1997;349:849.
17. Chang J, Ormerod M, Powles IJ, et al. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer 2000;89:2145.
18. Wheeler JA, Stephens LC, Tornos C, et al. ASTRO research fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical adenocarcinoma. Int J Radiat Oncol Biol Phys 1995;32:1487.
19. Chyle B, Pollack A, Bzerniak B, et al. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 1996;35:281.
20. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity, and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995;37:1.
21. Komaki R, Fujii T, Erkins P, et al. Apoptosis and mitosis as prognostic factors in pathologically staged NI non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phyd 1996;36:601.
22. van Engeland M, Nieland LJW, Ramaekers FCS, et al. Annexin-V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998;31:1.
23. Narula J, Acio ER, Narula N, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nature Med 2001;7:1347.
24. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000;356:209.
25. 99mTc-radiolabeled annexin-V. (abstr.) Radiology 1998;Suppl 11:1337.
26. 99m-annexin-V imaging study in heart transplant rejection: Can noninvasive detection of apoptosis in cardiac allografts obviate the need for endomyocardial biopsy. (abstr.) Circulation 2000;102:3714.
27. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin-V binding. J Lab Clin Med 1994;123:741.
28. Russell J, O'Donoghue JA, Finn R, et al. Iodination of annexin-V for imaging apoptosis. J Nucl Med 2002;43:671.
29. 123I-labeled human recombinant annexin-V. Biomol Eng 2001;17:51.
30. 123I-labeled annexin-V: A potential agent for SPECT imaging of apoptotic cells. J Labeled Compd Radiopharm 2000;43:739.
31. Glaser M, Collingridge DR, Aboagye EO, et al. Iodine-124-labeled annexin-V as a potential radiotracer to study apoptosis using positron emission tomography. Appl Radiat Isotopes 2003;58:55.
32. Fernandez MP, Morgan RO, Fernandez MR, et al. The gene-encoding human annexin-V has a TATA-less promoter with a high G+C content. Gene 1994;149:253.
33. Vaidyanathan G, Zulatsky MR. Protein radiohalogenation: Observations on the design of N-succinimidyl ester acylation agents. Bioconjugate Chem 1990;1:269.
34. 123I-rh-annexin-V in mice and humans. Nucl Med Commun 2003;24:871.
35. Yang DJ, Azkdarinia A, Wu P, et al. In vivo and in vitro measurement of apoptosis in breast cancer cells using Tc-99m-EC-annexin-V. Cancer Biother Radio 2001;16:73.
36. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci 1998;95:6349.
37. 99mTc-annexin-V. J Nucl Med 2003;44:92.
38. 99mTc-HYNIC annexin single photon emission computerized tomography. J Clin Oncol 2003;21:3483.
39. 99mTc recombinant human annexin-V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 2002;8:2757.